Download PDF
Planta Med 2011; 77(10): 1060-1067
DOI: 10.1055/s-0030-1270748
Biological Screening
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Inhibitory Effects of Terminalia chebula Extract on Glycation and Endothelial Cell Adhesion

Hyun-Sun Lee1 , Hong Yon Cho2 , Kuen-Woo Park3 , In-Hwan Kim4 , Jong-Tak Kim5 , Mi-Hyun Nam6 , Kwang-Won Lee6
  • 1Department of Food and Nutrition, Institute of Life Resources, Korea University, Seoul, Republic of Korea
  • 2Department of Food and Biotechnology, Korea University, Chungnam, Republic of Korea
  • 3Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University
  • 4Department of Food and Nutrition, Korea University, Seoul, Republic of Korea
  • 5Kocat, Inc., Bio Division, Geumcheon-gu, Seoul, Republic of Korea
  • 6Division of Food Bioscience & Technology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
Further Information

Publication History

received Oct. 17, 2010 revised January 10, 2011

accepted January 17, 2011

Publication Date:
09 February 2011 (online)

Also available at
    Permissions and Reprints

Abstract

Terminalia chebula Retz. has been used in India for a long time to treat many diseases, and its extract was reported to have antidiabetic activity in vivo. In this study, T. chebula methanolic extract (TCE) containing 2.7 % chebulic acid was evaluated for its preventive effects against the formation of advanced glycation end products (AGEs) and endothelial cell dysfuction. When the effects of TCE on AGE formation and on protein crossing-linking by glycation with D-threose and lens crystallines were examined, TCE showed inhibitory activity in a dose-dependent manner, and the concentration of 1000 µg/mL presented an activity similar to that of 5 mM aminoguanidine as a positive control. Upon investigating the protective activity of TCE against AGE-induced vascular endothelium dysfunction, human umbilical vein endothelial cells (HUVEC) incubated with 100 µg/mL of AGEs had significantly enhanced reactive oxygen species (ROS) formation, whereas the treatment of T. chebula reduced AGE-induced ROS generation. The incubation of HUVEC with 100 µg/mL of AGEs caused a considerable increase in THP-1 monocytic cell adhesion, but this adhesion was reduced by the treatment of TCE. These results suggest that TCE is a potential agent for alleviating diabetic complications.

Key words

Terminalia chebula Retz. - Combretaceae - advanced glycation end products - diabetic complications - antioxidant - lens crystalline

References

  • 1 Morello C M. Etiology and natural history of diabetic retinopathy: an overview.  Am J Health Syst Pharm. 2007;  64 S3-S7
    PubMedGoogle Scholar
  • 2 Brownlee M. Biochemistry and molecular cell biology of diabetic complications.  Nature. 2001;  414 813-820
    CrossrefPubMedGoogle Scholar
  • 3 Reddy V P, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.  Drug Discov Today. 2006;  11 646-654
    CrossrefPubMedGoogle Scholar
  • 4 Lingelbach L B, Mitchell A E, Rucker R B, McDonald R B. Accumulation of advanced glycation endproducts in aging male Fischer 344 rats during long-term feeding of various dietary carbohydrates.  J Nutr. 2000;  130 1247-1255
    PubMedGoogle Scholar
  • 5 Deelman L, Sharma K. Mechanisms of kidney fibrosis and the role of antifibrotic therapies.  Curr Opin Nephrol Hypertens. 2009;  18 85-90
    CrossrefPubMedGoogle Scholar
  • 6 Rao N, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats.  BMC Complement Altern Med. 2006;  6 17-22
    CrossrefPubMedGoogle Scholar
  • 7 Ishtiaq M, Hanif W, Khan M A, Ashraf M, Butt A M. An ethnomedicinal survey and documentation of important medicinal folklore food phytonims of flora of Samahni valley, (Azad Kashmir) Pakistan.  Pakistan J Biol Sci. 2007;  10 2241-2256
    CrossrefPubMedGoogle Scholar
  • 8 Dutta B K, Rahman I, Das T K. Antifungal activity of Indian plant extracts: Antimyzetische Aktivität indischer Pflanzenextrakte.  Mycoses. 1998;  41 535-536
    CrossrefPubMedGoogle Scholar
  • 9 Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell R R. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori.  Int J Antimicrob Agents. 2001;  18 85-88
    CrossrefPubMedGoogle Scholar
  • 10 Prasad L, Khan T H, Jahangir T, Sultana S. Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats.  Pharmazie. 2007;  62 790-797
    PubMedGoogle Scholar
  • 11 Senthilkumar G P, Subramanian S P. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats.  J Appl Biomed. 2006;  6 17
    PubMedGoogle Scholar
  • 12 Murali Y K, Anand P, Tandon V, Singh R, Chandra R, Murthy P S. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2007;  115 641-646
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Lee H S, Jung S H, Yun B S, Lee K W. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes.  Arch Toxicol. 2007;  81 211-218
    CrossrefPubMedGoogle Scholar
  • 14 Ahn M J, Kim C Y, Lee J S, Kim T G, Kim S H, Lee C K, Lee B B, Shin C G, Huh H, Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis.  Planta Med. 2002;  68 457-459
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Lee H S, Nam H W, Kyoung H K, Lee H, Jun W, Lee K W. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro.  Biol Pharm Bull. 2005;  28 1639-1644
    CrossrefPubMedGoogle Scholar
  • 16 Choi S Y, Jung S H, Lee H S, Park K W, Yun B S, Lee K W. Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract.  Phytother Res. 2008;  22 323-329
    CrossrefPubMedGoogle Scholar
  • 17 Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability.  Free Radic Biol Med. 1995;  18 29-36
    CrossrefPubMedGoogle Scholar
  • 18 Yildiz G, Demiryürek A T, Sahin-Erdemli I, Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence.  Br J Pharmacol. 1998;  124 905-910
    CrossrefPubMedGoogle Scholar
  • 19 Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L. Antioxidant properties of aminoguanidine.  Fundam Clin Pharmacol. 1999;  13 535-540
    CrossrefPubMedGoogle Scholar
  • 20 Thornalley P J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts.  Arch Biochem Biophys. 2003;  419 31-40
    CrossrefPubMedGoogle Scholar
  • 21 Tyagi N, Ovechkin A V, Lominadze D, Moshal K S, Tyagi S C. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia.  J Cell Biochem. 2006;  98 1150-1162
    CrossrefPubMedGoogle Scholar
  • 22 Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.  Life Sci. 2004;  75 1333-1341
    CrossrefPubMedGoogle Scholar
  • 23 Bustos P, Duffau C, Pacheco C, Ulloa N. [beta]-Sitosterol modulation of monocyte-endothelial cell interaction: a comparison to female hormones.  Maturitas. 2008;  60 202-208
    CrossrefPubMedGoogle Scholar
  • 24 Lee K W, Mossine V, Ortwerth B J. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro.  Exp Eye Res. 1998;  67 95-104
    CrossrefPubMedGoogle Scholar
  • 25 Webster J, Wilke M, Stahl P, Kientsch-Engel R, Munch G. Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases.  Z Gerontol Geriatr. 2005;  38 347-353
    CrossrefPubMedGoogle Scholar
  • 26 Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.  Ann Med. 1996;  28 415-418
    CrossrefPubMedGoogle Scholar
  • 27 Cohen J D. Overview of physiology, vascular biology, and mechanisms of hypertension.  J Manag Care Pharm. 2007;  13 S6-S8
    PubMedGoogle Scholar
  • 28 Calcutt N A, Cooper M E, Kern T S, Schmidt A M. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.  Nat Rev Drug Discov. 2009;  8 417-430
    CrossrefPubMedGoogle Scholar
  • 29 Brownlee M. Advanced protein glycosylation in diabetes and aging.  Annu Rev Med. 1995;  46 223-234
    CrossrefPubMedGoogle Scholar
  • 30 Lee H S, Koo Y C, Suh H J, Kim K Y, Lee K W. Preventive effects of chebulic acid isolated from Termialia chebula on advanced glycation endproduct-induced endothelial cell dysfunction.  J Ethnopharmacol. 2010;  131 567-574
    CrossrefPubMedGoogle Scholar
  • 31 Juang L J, Sheu S J, Li T C. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis.  J Sep Sci. 2004;  27 718-724
    CrossrefPubMedGoogle Scholar
  • 32 Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.  Atherosclerosis. 2008;  196 9-21
    CrossrefPubMedGoogle Scholar
  • 33 Jay D, Hitomi H, Griendling K K. Oxidative stress and diabetic cardiovascular complications.  Free Radic Biol Med. 2006;  40 183-192
    CrossrefPubMedGoogle Scholar

Prof. Kwang-Won Lee

Division of Food Bioscience & Technology
College of Life Science and Biotechnology
Korea University

5-ga, Anam-dong

Sungbuk-ku

Seoul 136-701

Republic of Korea

Phone: +82 2 32 90 30 27

Fax: +82 29 25 19 70

Email: kwangwon@korea.ac.kr